{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:24:32Z","timestamp":1759710272406,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.mehy.2020.110093","type":"journal-article","created":{"date-parts":[[2020,7,18]],"date-time":"2020-07-18T19:10:50Z","timestamp":1595099450000},"page":"110093","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Can neuromodulation support the fight against the COVID19 pandemic? Transcutaneous non-invasive vagal nerve stimulation as a potential targeted treatment of fulminant acute respiratory distress syndrome"],"prefix":"10.1016","volume":"143","author":[{"given":"Gregor A.","family":"Bara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"de Ridder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaroslaw","family":"Maciaczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2020.110093_b0005","unstructured":"John Hopkins University Corona Resource Center. Updated May 11, 2020."},{"key":"10.1016\/j.mehy.2020.110093_b0010","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0140-6736(20)30633-4","article-title":"Clinical course and mortality risk of severe COVID-19","volume":"395","author":"Weiss","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2020.110093_b0015","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2020.110093_b0020","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202003-0736LE","article-title":"Clinical course and outcomes of 344 intensive care patients with COVID-19","author":"Wang","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.mehy.2020.110093_b0025","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13054-020-2786-x","article-title":"Critical care response to a hospital outbreak of the 2019-nCoV infection in Shenzhen, China","volume":"24","author":"Liu","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.mehy.2020.110093_b0030","unstructured":"Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention."},{"issue":"1","key":"10.1016\/j.mehy.2020.110093_b0035","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5582\/bst.2020.01020","article-title":"Drug treatment options for the 2019-new corona virus (2019-nCoV)","volume":"14","author":"Lu","year":"2020","journal-title":"Biosci Trends"},{"key":"10.1016\/j.mehy.2020.110093_b0040","doi-asserted-by":"crossref","DOI":"10.5582\/bst.2020.01047","article-title":"Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies","author":"Gao","year":"2020","journal-title":"Biosci Trends"},{"issue":"20","key":"10.1016\/j.mehy.2020.110093_b0045","first-page":"30141","article-title":"Convalescent plasma as a potential therapy for COVID-19","author":"Chen","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.mehy.2020.110093_b0050","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(13)61048-X","article-title":"Adult haemophagocytic syndrome","volume":"383","author":"Ramos-Casals","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2020.110093_b0055","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","author":"Ruan","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.mehy.2020.110093_b0060","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.bbi.2005.03.015","article-title":"The cholinergic anti- inflammatory pathway","volume":"19","author":"Pavlov","year":"2005","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.mehy.2020.110093_b0065","first-page":"683","article-title":"Innervation of alveolar walls in the human lung: an electron microscopic study","volume":"131","author":"Fox","year":"1980","journal-title":"J Anatomy"},{"key":"10.1016\/j.mehy.2020.110093_b0070","doi-asserted-by":"crossref","first-page":"401","DOI":"10.4049\/jimmunol.0901808","article-title":"Requisite role of the cholinergic alpha7 nicotinic acetylcholine receptor pathway in suppressing gram-negative sepsis-induced acute lung inflammatory injury","volume":"184","author":"Su","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2020.110093_b0075","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12890-017-0436-0","article-title":"Regulating autonomic nervous system homeostasis improves pulmonary function in rabbits with acute lung injury","volume":"17","author":"Liu","year":"2017","journal-title":"BMC Pulmonary Med"},{"key":"10.1016\/j.mehy.2020.110093_b0080","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1084\/jem.20052362","article-title":"Splenectomy inactivates the cholinergic anti- inflammatory pathway during lethal endotoxemia and poly- microbial sepsis","volume":"203","author":"Huston","year":"2006","journal-title":"J Exper Med"},{"key":"10.1016\/j.mehy.2020.110093_b0085","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/35013070","article-title":"Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin","volume":"405","author":"Borovikova","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2020.110093_b0090","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jneuroim.2009.06.008","article-title":"Effects of vagus nerve stimulation on pro- and anti-inflam- matory cytokine induction in patients with refractory epilepsy","volume":"214","author":"De Herdt","year":"2009","journal-title":"J Neuroimmunol"},{"issue":"29","key":"10.1016\/j.mehy.2020.110093_b0095","doi-asserted-by":"crossref","first-page":"8284","DOI":"10.1073\/pnas.1605635113","article-title":"Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis","volume":"113","author":"Koopmann","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.mehy.2020.110093_b0100","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1553-2712.2012.01329.x","article-title":"Feasibility of percutaneous vagus nerve stimulation for the treatment of acute asthma exacerbations","volume":"19","author":"Miner","year":"2012","journal-title":"Acad Emerg Med"},{"issue":"1","key":"10.1016\/j.mehy.2020.110093_b0105","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1865-1380-6-7","article-title":"Non-invasive vagus nerve stimulation for the treatment of acute asthma exacerbations-results from an initial case series","volume":"6","author":"Steyn","year":"2013","journal-title":"Int J Emerg Med"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720312615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720312615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:32:51Z","timestamp":1759692771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987720312615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":21,"alternative-id":["S0306987720312615"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2020.110093","relation":{},"ISSN":["0306-9877"],"issn-type":[{"type":"print","value":"0306-9877"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can neuromodulation support the fight against the COVID19 pandemic? Transcutaneous non-invasive vagal nerve stimulation as a potential targeted treatment of fulminant acute respiratory distress syndrome","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2020.110093","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110093"}}